Pfizer, Allele Biotech End COVID Vax IP Fight

By Adam Lidgett (January 5, 2022, 4:14 PM EST) -- Allele Biotechnology and Pharmaceuticals Inc. has agreed to drop its suit in California federal court alleging that Pfizer and BioNTech poached research technology while testing their jointly produced COVID-19 vaccine.

In a short joint motion to dismiss filed Tuesday, Allele, Pfizer and BioNTech asked the court to dismiss Allele's suit with prejudice, although no further details were publicly available as to why the parties agreed to dismissal.

The joint motion came about eight months after U.S. District Judge Marilyn L. Huff in May denied Pfizer and BioNTech's motion to dismiss the suit over Allele's patented fluorescent protein called mNeonGreen, which Allele...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!